Dr. Peihong Wu, is a professor of Sun Yat-sen University, visiting professor of School of Medicine University of Rochester, USA, and visiting professor of School of Medicine University of Toronto, Canada. He is also the president of the Society of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association; and the director of the Department of Medical Image and Image Guided Therapy, Sun Yat-sen University Cancer Center.He has published 6 books, more than 130 papers in non-SCI journals and 40 peer-reviewed papers on image diagnosis and image-guided therapy in oncology.
1998-present Director and Professor of the Department of Medical Image and Image Guided Therapy, Sun Yat-sen University Cancer Center
1999-2000 Visiting scholar. Interventional Radiology and Imaging Diagnosis MD Anderson Cancer Center
2001-present Member of Standing Committee of Interventional Therapy on Oncology, Chinese Anti-Cancer Association
2006-present President of the Society of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association2007-present Chairman of the Committee of Minimally Invasive Therapy and Integrated Therapy for Hepatocellular Carcinoma, Chinese Anti-Cancer Association
2010-present Member of Academic Committee Sun Yat-sen University Cancer Center
2010-present Member of Medical Quality Management Committee Sun Yat-sen University Cancer Center
2013-present Award of TOP10DR in interventional radiology in China
2014-present Award of the most outstanding doctors in Sun Yat-sen University
2014-present Member of Board Director of Asian Tumor Ablation Association
2014-present Executive Member of Board Director of Asian Pacific Image-guided Therapy Association.
1. Combination of image-guided minimally invasive therapy with chemotherapy, radiotherapy and surgery.
2. Image-guided minimally invasive therapy combined with bio-immunotherapy.
3. Constructive model and strategy for cancer treatment: at the basis of effective elimination of malignant tumor, maximize the physical function, immunity and life quality of patients.
1982 M.D. Sun Yat-sen University, Guangzhou, China
1982-1985 Resident, Radiology and Clinical Oncology
1985-1988 Fellow, Radiology and Interventional Radiology
1988-1995 Attending Doctor, Department of Radiology and Interventional Radiology
|Title||Director, chief physician and doctoral advisor|
Prof. Xie Chuanmiao graduated from Department of Clinical Medicine, former Sun Yat-sen University of Medical Sciences in 1988. Currently, he serves as the director for the Department of Imaging at the Sun Yat-sen University Cancer Center, Chief Physician and Doctoral Advisor. He has engaged himself in medical image diagnosis for over 20 years, so he is skillful in knowledge of medical image diagnosis, and he has unique insights into the diagnosis and research of nasopharyngeal carcinoma, breast cancer and liver cancer. Also, he acquires a wealth of experience in imaging diagnosis of intractable cases.
1. Functional magnetic resonance imaging and energy spectrum CT
2. Medical image diagnosis of nasopharyngeal carcinoma
3. Medical image diagnosis of liver cancer and breast diseases
1. MRI signal changes in the skull base bone after endoscopic nasopharyngectomy for recurrent NPC: a serial study of 9 patients. Eur J Radiol 2013, 82(2):309-315.
2. Computed tomography characterization of neuroendocrine tumors of the thymus can aid identification and treatment. Acta Radiol 2013, 54(2):175-180.
3. An experimental study on acute brain radiation injury: dynamic changes in proton magnetic resonance spectroscopy and the correlation with histopathology. Eur J Radiol 2012, 81(11):3496-3503.
4. A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer. Eur J Radiol 2012, 81(10):2602-2612.
5. Primary nasopharyngeal non-Hodgkin''''''''s lymphoma: imaging patterns on MR imaging. Clin Imaging 2012.
6. Magnetic resonance imaging features of nasopharyngeal carcinoma and nasopharyngeal non-Hodgkin''''''''s lymphoma: are there differences? Eur J Radiol 2012, 81(6):1146-1154.
7. Nasopharyngeal adenoid cystic carcinoma: magnetic resonance imaging features in ten cases. Chin J Cancer 2012, 31(1):19-28.
8. Diffusion-weighted magnetic resonance imaging for prediction of response of advanced cervical cancer to chemoradiation. J Comput Assist Tomogr 2011, 35(1):102-107.
9. Computed tomographic findings of skull base bony changes after radiotherapy for nasopharyngeal carcinoma: implications for local recurrence. J Otolaryngol Head Neck Surg 2011, 40(4):300-310.
10. Kimura's disease: the CT and MRI characteristics in fifteen cases. Eur J Radiol 2011, 80(2):489-497.
|Title||Professor and Chief Physician|
Dr. Zhang is a professor and deputy director of the Institute of Medical Imagingand Interventional Radiology. Dr. Zhang obtained his Bachelor in Medicine (equivalent to MD in theUS) at Bethune Medical University and PhD at the Second Military Medical University, China in 1997 and 2006, respectively. As a visiting scholar, he learned at the MolecularI maging Research Center, Baylor College of Medicine, USA in 2008. He specializes in minimally invasive treatment of cancer (liver cancer, lung cancer and other solid tumors) and molecular imaging diagnosis and treatment. He took the lead to carry out the tumor ablation (RFA, PMCT, Cryoablation) and radioactive iodine-125 brachy therapy in China. He presided over a number of national and provincial research projects. Recent years, as the first author and corresponding author, he has published more than 70 research papers (including Oncotarget, BBA-Gene Regulatory Mechanisms, etc.) and edited several books.
|Research Interest(s)||Minimally invasive treatment of cancer (liver cancer, lung cancer and other solid tumors) and molecular imaging diagnosis and treatment.|
1987: Graduated from undergraduate medical program at Inner Mongolia Medical University.
1997: Obtained a master’s degree in medical imaging and nuclear medicine from Norman Bethune College of Medicine Jilin University.
2006: Obtained a doctoral degree in medical imaging and nuclear medicine from Second Military Medical University
09/2008-12/2008: Acted as a visiting scholar in the Department of Radiology, U.S. Baylor College of Medicine
1．Osteosarcoma:Limb salvaging treatment by ultrasonogrphically guided high intensity focused ultrasound.CancerBiolTher 2009;(12)1102-1108
2．Superficial malignant tumors:Non-invasive treatment with ultrasonographically guided high-Intensity focused ultrasound.CancerBiolTher 2009;8(24)(December15;2009)
3．Short to mid term evaluation of CT-guided I125 brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma.CancerBiol Ther.2009;8(7):585-590
4. Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 2010 Nov;136(11):1633-40
5. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound.Cancer. 2010 Aug 15;116(16):3934-42.
6. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. European Journal Cancer. 2010 Sep;46(13):2513-21
7. Microwave ablation treatment of liver cancer with 2,450-MHz cooled-shaft antenna: an experimental and clinical study.Journal of Cancer Research and Clinical Oncology. 2010 Oct;136(10):1507-16
8. An imageable retinoid acid derivative to detect human cancer xenografts and study therapeutic dosing to reduce its toxicity.Contrast Media Mol Imaging. 2010 Nov 30. [Epub ahead of print]
9. Computed tomography and magnetic resonance imaging findings of peripheral primitive neuroectodermal tumors of the head and neck. European Journal of Radiology. 2011 Feb [Epub ahead of print]
10. Ke, S. and F. Zhang, et al. (2012). "Multiple target-specific molecular imaging agents detect liver cancer in a preclinical model." CurrMol Med 12 (8): 944-51.
11.Hu, X. and H. Qiu, et al. (2012). "Recurrent gliomas: comparison of computed tomography (CT)-guided 125I seed implantation therapy and traditional radiochemotherapy." Cancer BiolTher 13 (10): 840-7.
12. Peng, S. and Q. X. Yang, et al. (2014). "Lobaplatin-TACE combined with radioactive 125I seed implantation for treatment of primary hepatocellular carcinoma." Asian Pac J Cancer Prev 15 (13): 5155-60.
13. Yang, G. and S. Zhang, et al. (2014). "Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1." Biochim Biophys Acta 1839 (9): 837-48.
14. Yang, G. and S. Zhang, et al. (2014). "The inhibitory effects of extracellular ATP on the growth of nasopharyngeal carcinoma cells via P2Y2 receptor and osteopontin." J Exp Clin Cancer Res 33: 53.
15. Zhang, T. and M. Lu, et al. (2014). "CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy." J Cancer Res Clin Oncol 140 (8): 1383-90.
16. Yang, G. and S. Peng, et al. (2014). "Cell-based assay system to estimate the effect of 125I seeds on cancer cells: effect of osteopontin." Recent Pat Anticancer Drug Discov 9 (2): 258-63.
17. Zhang, W. and Y. Zhang, et al. (2014). "Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components." Oncotarget 5 (8): 2221-9.
18. Liu, Z. and F. Gao, et al. (2014). "Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis." Tumour Biol.
|Title||Professor, advisor of master’s degree student|
Prof. Huang Jinhua has engaged himself in professional clinical practice for over 20 years, accumulated abundant experience in interventional treatment and minimally invasive surgery for cancer and is proficient in curing cancers with various technologies of minimally invasive surgery and treatment. The primary interventional treatment technologies and the cancers cured include: 1. transarterial chemoembolization of liver cancer; 2. transarterial infusion of cancer; 3. ablation of liver cancer, lung cancer, kidney cancer and other solid tumors with radiofrequency and ablation; 4. comprehensive interventional and minimally invasive treatment for gynecologic refractory tumors; 5. implantation of radioactive particles into tumors; 6. (esophageal stricture, obstruction of biliary tract and venous stenosis) endovascular stent implantation.
1985: Graduated from School of Medicine, Medical College of Nanchang University (undergraduate)
1992: Obtained a master’s degree from Shanghai Jiao Tong University School of Medicine (SJTUSM)
2003 – 2004: Studied in MD Anderson Cancer Center, US
1. Radioablation settings affecting the size of lesions created ex vivo in porcine livers with monopolar perfusion electrodes. Acad Radiol 2010;17(8): 980-984.
2. Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture. World J Gastroenterol 2010；16(45): 5766-5772.
3. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: Correlation with histopathologic findings. Eur J Radiol 2010.
4. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol 2007，13(48):6593-6597.
|Title||Professor, chief physician and doctoral advisor|
Prof. Fan Weijun has been working in the Department of Imaging and Minimally Invasive Surgery, Sun Yat-sen University Cancer Center since 1999. He currently serves as Chief Physician in the Department of Imaging and Minimally Invasive Surgery, Sun Yat-sen University Cancer Center and advisor of master’s degree student. He primarily engages himself in imaging diagnosis and interventional treatment for cancer, specializes in imaging diagnosis and interventional treatment for various cancers, and particularly, owns an in-depth research on the treatment of cancer with microwave and radiology, and conducts large numbers of basic and clinical research. He has published 31 papers as the first author or corresponding author, including 6 SCI papers, 15 papers in domestic magazines and has edited or participated in compiling 5 academic monographs. Specifically, he serves as the editor in chief of Clinical Oncology,Minimal Invasive Treatment and associate editor in chief of Multidisciplinary Compositive Treatment of Liver Cancer and Interventional Diagnosis and Treatment in Oncology, and took part in writing Neuroimaging, Nasopharyngeal Carcinoma and Helical CT Diagnosis. He is at present undertaking a number of subjects with Guangdong Provincial Department of Science and Technology, Health Department of Guangdong Province and Science and Information Technology of Guangzhou, gets involved in National Key Technologies R&D Program of China during the 9th Five-Year Plan Period, 211 Project, key disciplinary construction of cancer and other research projects.
1． CT-guided percutaneous microwave ablation of adrenal malignant carcinoma: preliminary results. Cancer. (In Press)
2． Comparison of microwave ablation and multipolar radiofrequency ablation, both using a pair of internally cooled interstitial applicators: Results in ex vivo porcine livers. International Journal of Hyperthermia. (In Press)
3． Comprehensive sequential interventional therapy for hepatocellular carcinoma. Chin Med J (Engl). 2009 Oct 5;122(19):2292-8.
4． Research on focal nodular hyperplasia with MSCT and postprocessing. World J Gastroenterol. 2009 Oct 14;15(38):4838-43.
5． Evaluating transcatheter arterial chemoembolization for primary hepatic cancer by magnetic resonance diffusion-weighted imaging. Chin Med J (Engl). 2008 Nov 20;121(22):2353-6.
6． Radiofrequency ablation as a treatment for hilar cholangiocarcinoma. World J Gastroenterol. 2008 Jul 28;14(28):4540-5.
|Title||Chief physician, advisor of master’s degree student|
Zhao Ming was appointed as the associate chief physician, associate professor and advisor of master’s degree student at Sun Yat-sen University Cancer Center. He is familiar with human imaging anatomy and imaging vascular anatomy and proficient in interventional diagnosis and treatment for solid tumors, such as interventional chemoembolization and radiofrequency ablation of primary liver cancer and metastatic colorectal cancer, integrated application of molecular targeted therapy, radiofrequency ablation of lung cancer and lung metastatic tumors and integrated application of TACE, TAI and molecular targeted therapy; palliative treatment for advanced tumors, such as drainage of and stent implantation of obstructive jaundice, stent implantation in the esophagus, stent implantation in the vena cava, image-guided implantation of radioactive particles under, nerve compression and interventional treatment for pain palliation of metastatic bone tumors. He is able to grasp the developments in cancer treatment and provide out-patient medical advice and popularization of science, and attends clinical and multidisciplinary consultations on hepatobiliary diseases for chief scientists. With regard to single diseases, he owns an in-depth research on and abundant clinical experience in hepatic metastases, which he also regards as his basis for research.
Guided by the concept of single disease sand multidisciplinary integrated treatment, he systematically carries out clinical research on liver tumors and solid tumors in the lung and gradually implements the concept of integrating interventional treatment and minimally invasive surgery planning system into individualized treatment; conducts real-time ablation treatment for tumors under the guidance of MRI and performs local treatment for such solid cancers as liver cancer, lung cancer and retroperitoneal cancer with various means of minimally invasive surgery including nano-knife. Taking prolong survival as the goal, he analyzes factors concerning the systemic immunity of tumors’ recurrence and gradually takes measures of intervention clinical treatment by studying immune regulation of recurrent primary liver cancer and its immune tolerance mechanism.
January 2014: appointed as the Chief Physician of Sun Yat-sen University Cancer Center;
September 2008: short-term study in Barcelona Clinic Liver Cancer (BCLC);
1997-2000: received specialist training of cancer and obtained a master’s degree in oncology from Sun Yat-sen University (former Sun Yat-sen University of Medical Sciences);
1993-1997: completed clinical training for resident physicians at the First Affiliated Hospital of Bengbu Medical College
1. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. Am J Roentgenol.2013;201(6):1362-7.
2. Transcriptomic profiling of Aspergillusflavus in response to 5-azacytidine. Fungal Genet Biol. 2013;56:78-86.
3. Chromosomal evolution of Escherichia coli for the efficient production of lycopene. BMC Biotechnol 2013;13(1):6.
4. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. International Journal of Hyperthermia 2012;28:721-728.
5. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement. Eur J Radiol 2012;81(10):2717-2725.
6. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation. Eur J Radiol 2012;81(4):e473-e477.
7. Retroperitoneal schwannoma treated with percutaneous computed tomography-guided radiofrequency ablation. J Neurosurg Spine 2012;17(2):173-176.
8. Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature. Exp Ther Med 2012; 4:334-338
9. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma. Int J Hyperthermia 2011; 27(6):549-554.
10. Huge refractory retroperitoneal nerve sheath tumor treated with radiofrequency ablation: a case report with literature review. Chin J Cancer 2010; 29(4):463-6.
|Title||Professor of Radiology|
Dr. Zhenfeng Zhang is a professor of Radiology at the Center of Medical Imaging and Image-guided Therapy of Sun Yat-sen University Cancer Center (SYSUCC). Dr. Zhang obtained his Bachelor in Medicine (equivalent to MD in the US) at Three Gorges University College of Medical Science, Hubei, P. R. China in 1992 and PhD at Case Western Reserve University, Cleveland, USA in 2010, respectively. His postdoctoral training at Case Western Reserve University and Columbia University Medical Center provided him with great opportunities to explore the fields of tumor biology, tumor metastasis, and drug resistance of EGFR-targeted therapy for lung cancer. He returned the Center of Medical Imaging and Image-guided Therapy at SYSUCC as a physician-scientist in March 2013, and established a molecular imaging lab focusing on CT/MRI molecular imaging studies. Dr. Zhang has published more than 10 peer reviewed research papers in Nature Genetics, Oncotarget, Carcinogenesis, et. al.
Clinical research on medical imaging diagnosis and imaging-guided therapy for cancer;
Molecular Imaging for Oncology;
Immunotherapy for lung cancer;
Radiomics on lung cancer and NPC;
Basic and translational research on targeted therapy for lung cancer and breast cancer.
Ph.D. 2010, Pathology, Case Western Reserve University, Cleveland, Ohio, USA. M.S.
1999, Radiology, Sun Yat-sen University of Medical Sciences, Guangzhou, China. B.S.
1992, Medicine, Three Gorges University College of Medical Science, Hubei, China.
1. Yang L, Rozenfeld R, Wu D, Devi AL, Zhang Z*, Cederbaum IA*. Free Radical Biology & Medicine, DOI: 10.1016/j.freeradbiomed. (2014). * Co-corresponding author. IF 5.2712.
2. Cheng H, Zhang Z, Borczuk AC, Powell CA, Halmos B. Carcinogenesis, 34(4): 739-49 (2013). IF 5.6353.
3. Wang X, Li G, Wang A, Zhang Z, Merchan JR, Halmos B. Molecular Carcinogenesis, 52(3): 218-28 (2013). IF 4.2694.
4. Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T , Abdel-Rahman M , Wang X , Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG. Nature Genetics, 44(8):852-860 (2012). IF 35.2095.
5. Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B. Oncotarget, 1(7): 497-514 (2010). IF 6.6366.
6. Zhang Z, Kobayashi S, Leidner RS, LaFramboise T, Levine AD, Halmos B. Carcinogenesis, 31(4):577-586(2010). IF 5.635
Last Updated on: July 2015
|Title||Professor, chief physician, doctoral advisor|
Prof. Li Li has long engaged himself in research of medical imaging diagnosis and molecular imaging and attains significant results in producing smart magnetic resonance contrast media, studying novel nanoprobes, multi-staging and multi-modal molecular imaging theory of tumor molecules and studies on animal models. He is the person in charge of the project of State Key Laboratory of Oncology in South China (2004DA105074) and the seventh batch of provincial training target in the “Thousand Hundred Ten Talents Cultivation Project” of universities in Guangdong Province.
1. Cao CY, Shen YY, Wang JD, Li L*, Liang GL*. Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents. Sci Rep 2013,3,1024 doi:10.1038/srep01024 (2013).
2. Tian XM, Shao YZ, He HQ, Liu H, Shen YY, Huang WL*, Li L*. Nanoamplifiers synthesized from gadolinium and gold nanocomposites for magnetic resonance imaging. Nanoscale 2013, 5(8), 3322-3329
3. Shen Y, Shao Y, He H, Tan Y, Tian X, Xie F*, Li L*. Gadolinium(3+)-doped mesoporous silica nanoparticles as a potential magnetic resonance tracer for monitoring the migration of stem cells in vivo. Int J Nanomedicine 2013,8:119-127
4. Cai HM, Cui CY, Tian HY, Zhang M, Li L*. A novel approach to segment and classify regional lymph nodes on computed tomography images. Comput Math Method M 2012,2012:145926 doi:10.1155/2012/ 145926
5. Shao YZ, Tian XM, Hu WY, Zhang YY, Liu H, He HQ, Shen YY, Xie FK, Li L*. The properties of Gd2O3-assembled silica nanocomposite targeted nanoprobes and their application in MRI. Biomaterials 2012,33(27):6438-6446
6. Feng YP, Liu QC, Zhu JF, Xie FK, Li L*. Efficiency of ferritin as an MRI reporter gene in NPC cells is enhanced by iron supplementation. J Biomed Biotechnol 2012,2012:434878 doi:10.1155/2012/434878
7. Pang YC#, Li L#, Hu WY, Peng YX, Liu LZ, Shao YZ*. Computerized segmentation and characterization of breast lesions in dynamic contrast-enhanced MR images using Fuzzy c-means clustering and snake algorithm. Comput Math Method M 2012,2012:634907 doi:10.1155/2012/634907 (2011 SCI IF 0.684)
8. Cui CY, Cai HM, Liu LZ, Li LR, Tian HY, Li L*. Quantitative analysis and prediction of regional lymph node Status in rectal cancer based on computed tomography imaging. Eur Radiol 2011,21(11):2318-2325
9. Shao YZ, Liu LZ, Song XQ, Cao RH, Liu H, Cui CY, Li X, Bie MJ, Li L*. A novel one-step synthesis of Gd3+ incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent. Contrast Media Mol Imaging 2011,6(2):110-118
10. Feng YP, Liu QC, Zhu JF, Xie FK, Li L*. Development and applications of a nasopharyngeal carcinoma Tet-Off cell line. Oncol Lett 2011, 3(2):525-530
11. Shao YZ, Liu LZ, MJ, Li CC, Wu YP, Xie XM, Li L*. Characterizing the clustered microcalcifications on mammograms to predict the pathological classification and grading: a mathematical modeling approach. J Digital Imaging 2011, 24(5):764-771
12. Liu LZ, Liang SB, Li L*, Mao YP, Tang LL, Tian L, Liao XB, Cui CY, Lin AH, Ma J*. Prognostic impact of magnetic resonance imaging-detected cranial nerve involvement in nasopharyngeal carcinoma. Cancer 2009,115(9):1995-2003
13. Cui CY, Liu LZ, Ma J, Liang SB, Tian L, Tang LL, Li L*. Trigeminal nerve palsy in nasopharyngeal carcinoma: Correlation between clinical findings and magnetic resonance imaging. Head Neck 2009,31(6):822-828
14. Li L, Liu LZ, Wu QL, Mo YX, Liu XW, Cui CY, Wan DS*. CT-guided core needle in diagnosis of pancreatic diseases with an automated biopsy gun. J Vasc Interv Radiol 2008,19(1):89-94
15. Ma J, Liu L, Tang L, Zong J, Lin A, Lu T, Cui N, Cui C, Li L*. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res 2007,13(5):1445-1452
16. Liu LZ, Zhang GY, Xie CM, Liu XW, Cui CY, Li L*. Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread. Int J Radiat Oncol Biol Phys 2006,66(3):721-730
17. Li L, Wu PH, Huang JL, Liu RY, Zeng YX, Huang WL*. Adenovirus-mediated intra-tumoral delivery of the human endostatin gene inhibits tumor growth in nasopharyngeal carcinoma. Int J Cancer 2006,118(8):2064-2071
|Title||Associate chief physician|
Associate chief physician Dep. of Medical Imaging and interventional Radiology, cancer center, Sun Yat-Sen University, Guangzhou, P. R. China Dec. 2008 to present
Attending Resident Dep. of Medical Imaging and interventional Radiology, cancer center, Sun Yat-Sen University, Guangzhou, P. R. China Jul. 2000~Dec. 2008
Resident Dep. of Medical Imaging and interventional Radiology, cancer center, Sun Yat-Sen University, Guangzhou, P. R. China Jun.1999 to Jul. 2000
Resident Dep. Of Medical Imaging, Feicheng Mine Bureau, Feicheng City, Shandong Province, P. R. China Jul. 1992 to Aug. 1996
|Research Interest(s)||Medical imaging of central nervous system|
Weifang Medical College, Weifang City, Shandong Province, P.R. China Bachelor Sep.1987~Jul. 1992．12 Medicine
Sun Yat-Sen University of Medical Sciences, Guangzhou, P.R. China Master Aug.1996~ Jun.1999 Medical Imaging
1. The application of contrast enhanced perfusion weighted magnetic resonance imaging in differential diagnosis between benign and malignant musculoskeletal neoplasms. Chinese Journal of radiology, Aug. 2001; 35(8):578-583
2. Observation of the changes of ADC value of experimental cerebaral infarction with diffusion weighted magnetic resonance imaging. Chin J Nerv Ment Dis. sep.2002; 28(5):348-350
3. Experimental stuties on the identification of focal brain ischemic penumbra with diffusion / perfusion weighted magnetic resonance imaging. Chin J Nerv Ment Dis. May 2000; 26(3):148-151
4. Clinical value of CT perfusion in the differential diagnosis of parofid gland tulllors. Clin J Radiol.September 2007;41(9):922-925
5. CT Features of Parotid Tumors：An Analysis of 1 33 Cases. chinese Journal of Cancer，2007; 26(11)：1263-1267
6. Malignant Epithelial Parotid Tumors：CT Imaging and HistOpathOlOgic Correlation. Chinese Journal of Cancer，2007，26(7)：762-766
7. Application of MR spectroscopy in differential diagnosis between basicranial turflor recurrence and radiation encephalopathy after radiotherapy for nasoplmryngeal carcinoma. Clin J Radiol. July 2008; 42(7):714-719
8. Comparison of CT perfusion between advanced gastric cancer and gastric lymphoma. Chin J Biomed Eng. Aug. 2008;14(4):306-308
9. Comparison of CT Findings between Gastric Cancer and Gastric Lymphoma. Chinese Journal of Cancer，2008，27(5)：539-543
10. CT Features of 25 Cases with Gastric Lymphomas. JOURNAL OF SUN YAT-SEN UNIVERSITY(MEDICAL SCIENCES. 2008;29(1):103-107
11. A case reprot of cystrophy on aberrant pancreas of rhe duodenal well. 2010. 90(17): 1223-1224
12. Ke Sai, Yong-gao Mou, Jing Zeng, Yan-chun Lv。Sai et al. Neurosurgical interventions for patients withnasopharyngeal carcinoma: a single institution experience. World Journal of Surgical Oncology 2013, 11:227
1. Chief Editor of Medical Imaging Diagnosis of Nasopharygeal Carcinoma， published soon by Publishing House of People’s health，China. 2007.
2. Editor of Diagnostic Spiral CT, Published by Publishing House of Guangdong science and Technique, China.
3. Editor of MRI guide for clinical phsician, Published by Publishing House of Science and Technique, Beijing, China. Jun. 2003
Last Updated on: July 2015
|Title||Associate Chief Physician, Postgraduate Tutor, Doctor of Medicine|
Published 32 papers in recent years including 27 SCI articles, first or corresponding author in 19 SCI articles, IF total 56.589, 3 articles IF>5.
Reviewer of the following magazines: Surgery, Am J Clin Oncol, Liver International, Hepatology International,Journal of Clinical Trials, International Journal of Nanomedicine, Journal of Nasopharyngeal Carcinoma.
The first to propose HIFU treatment of malignant bone tumors in the form of SCI papers internationally. Its contents were published in Cancer 2010; 116:3934-42 and Cancer Biol Ther 2009;8:1102-8 magazine, obtained high-end concern from medical community.
The first to propose in the form of SCI papers internationally the lung metastasis of HCC after liver transplantation, the use of 125I particles for regional treatment in combination with systemic therapy of sorafenib which obtained significant effect. Its contents were published in J Cancer Res Clin Oncol. 2010;136(11):1491-9 magazine.
Published first international SCI paper proposing nasopharyngeal carcinoma patients after adequate treatment and dose chemotherapy cannot undergo re-surgery, chemotherapy and external radiotherapy. Nasopharynx and cervical tumor recurrence can be treated with 125I seed implantation. It was published in Otolaryngology-Head Neck Surgery 2013;149(3):417-23 magazine.
In the past five years, there has been a large number of statistical studies of 15,000 liver cancer patients of our hospital for 20 years looking for different reasons for different survival period of the patients. Its contents were published in World J Gastroenterol 2013;21;19(23):3649-57 magazines. On searching for the reasons for different survival period in HCC patients, it has been found by microarray gene analysis that three different genes were related to different survival period of HCC patients. The studies concerning mechanism of the gene functions are underway. At the same time imaging pixel level analysis of the relationship between CT imaging features and the survival period at molecular level has made it possible to obtain the prediction of 5 year survival probability of patients and its sensitivity and specificity. Estimation of more accurate prognosis of patients has an important guiding value for individualized treatment plan for the patient.
1. Experimental research on a novel Iodine-125 seed strand connected using magnesium alloy AZ31. Recent Pat Anticancer Drug Discov. 2014 Jan 30.
2. Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components. Oncotarget (In Press).
3.Nasopharyngeal carcinoma: Imaging diagnosis and progress. Journal of Nasopharyngeal Carcinoma. 2014 (In Press).
4. Metastatic malignant melanoma: CT-guided 125I seed implantation treatment. Mlanoma Res. 2013;149(3):417-23.
5. Hepatocellular carcinoma: clinical study of long-term survival and choice of treatment modalities. World J Gastroenterol. 2013; 21; 19(23):3649-57. 1
6. Refractory nasopharyngeal carcinoma: positron emission tomography combined with computed tomography-guided 125I seed implantation therapy after repeated traditional radiochemotherapy. Otolaryngol Head Neck Surg. 2013;149(3):417-23.
7. Refractory malignant fibrous histiocytoma: CT-guided treatment with a multidisciplinary, minimally invasive approach. Technol Cancer Res Treat. 2013 Dec 6.
8. A meta-analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorectal cancer. Colorectal Disease 2012;14(3):80-9. 6
9. CT imaging of primary pleuropulmonary synovial sarcoma. Clin Radiol. 2012;67:884-8.
10. Reply to high-intensity focused ultrasound is not indicated for treatment of primary bone sarcomas. Cancer 2011; 117(12):2822-3 3
11. Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: Chemoembolization and stent combined with iodine-125 seed. Cancer Biol Ther 2011:12:865-71. 6
12. Microwave ablation: results in ex vivo and in vivo porcine livers with 2450-MHz cooled-shaft antenna. Chin Med J. 2011;124:3386-93. 5
13. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound. Cancer 2010;116(16):3934-42. 30
14. Therapeutic effects and prognostic factors in high-Intensity focused ultrasound combined with chemoembolization for larger hepatocellular carcinoma. Eur J Cancer 2010;46:2513-21.
15. Microwave ablation treatment of liver cancer with 2450-MHz cooled-shaft antenna: an experimental and clinical study. J Cancer Res Clin Oncol 2010;136:1507-16. 12
16. Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136(11):1491-9.
17. Osteosarcoma: Limb salvaging treatment by ultrasonographically guided high intensity focused ultrasound. Cancer Biol Ther 2009;8(12):1102-8.
18. Superficial malignant tumors: Non-invasive treatment with ultrasonographically guided high-Intensity focused ultrasound. Cancer Biol Ther 2009;8(24):74-81.
19. Analysis of clinical effect for liver cancer using high intensity focused ultrasound. World J Gastroenterology 2004;10(15):2201-4.
20. Comprehensive sequential interventional therapy for hepatocellular carcinoma. Chin Med J 2009;122:2292-8.
21. Short to mid-term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma. Cancer Biol Ther 2009;8(7):22-4.
22. Inflammatory myofibroblastic tumour of the maxillary sinus: CT and MRI findings. Clinical Radiology 2012.
23. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: Correlation with histopathologic findings. Eur J Radiol 2011; 80:269-73.
24. Computed tomography and magnetic resonance imaging findings of peripheral primitive neuroectodermal tumors of the head and neck. Eur J Radiol 2011;8(2): 607-11
25. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and 18F fluorodeoxyglucose positron emission tomography/computed tomography imaging findings and follow-up. J Comput Assist Tomogr 2011;35:608-13
26. CT-guided (125) I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: effectiveness and safety in 16 patients. Eur J Radiol.2012 Oct 3.
27. CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma.Chin Med J. 2008;121(23):2410-14.
|Title||Associate chief physician|
Born in November 1968, Dr. Li Yizhuo obtains a doctoral degree in oncology from Sun Yat-sen University. Currently, he serves as the associate chief physician for the Department of Imaging at the Sun Yat-sen University Cancer Center, works on oncology imaging and he specializes in imaging diagnosis of oncology.
1. Guo-Yi Zhang , Li-Zhi Liu, Wei-Hong Wei, Yan-Ming Deng, Yi-Zhuo Li* , Xue Wen Liu Radiologic Criteria of Retropharyngeal Lymph Node metastasis in Nasopharyngeal Carcinoma Treated with Radiotherapy. Radiology, 2010, 255(2): 605-612.
2. Yi-Zhuo Li, PeiQiang Cai, Chun-Miao Xie, Zi-Lin Haung, Guo-Yi Zhang, Yao-Pan Wu, Li-Zhi Liu, Ci-Yong Lu, Rui Zhong, Pei-Hong Wu*. Nasopharyngeal cancer: Impact of skull base invasion on patients prognosis and its potential implications on TNM staging. Eur. J. of Radiology. 2013; 82(3): e107-e111.
Prof. Lizhi Liu is a Radiologist at Sun Yat-sen University Cancer Center. He received his BS degree in North Sichuan Medical University in 1996, and his MS and MD degrees in Sun Yat-sen University in 2008 and 2016, respectively. He was a visiting Associate professor in the Department of Radiology and Imaging Sciences of Emory University. He is the author of more than 40 journal papers. His current research interests including oncologic imaging and medical image analysis.
1996-2002 Residency, Radiology, Cancer Center, Sun Yat-sen University of Medical Sciences, Guangzhou, P.R.China
2002-2005 Clinical fellow, Radiology, Sun Yat-sen University Cancer Center, Guangzhou, P.R.China
2005-2008 Attending Radiologist, Radiology, Center for Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China
2008-present Associate professor, Radiology, Center for Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China
2014-2015 visiting Associate professor, Department of Radiology and imaging science, Emory University, Atlanta, CA, America
2016-2018 Professor, Radiology, Center for Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China
Awards and Honors
2007 Second Prize of Institutions of Higher Education Science and Technology Award, Ministry of Education of China
The cranial nerve involvment in nasopharyngeal carcinoma: prognosis, molecular mechanism and animal model, Science and Technology Plan Project of Guangdong Province, 50,000 RMB, NO. 2013B021800073, Principal Investigator.
The effect of neoneurogenesis on the growth, invasion and metastases of nasopharyngeal carcinoma cells, the Science Foundation of Guangdong Province, 100,000 RMB, NO. 2014A030313137, Principal Investigator.
The effect of neoneurogenesis in nerves promoting the invasion and metastases of nasopharyngeal carcinoma cells: molecular mechanism, the National Science Foundation of China 250,000 RMB, NO. 81572652, Principal Investigator.
Radiology, Nasopharyngeal carcinoma
B.S 1996 - North Sichuan Medical University , Nanchong, P.R. China
M.S. 2004 - Center for Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China Advisor: Professor Peihong Wu, M.D. Thesis: Correlation of Parameters of Dynamic Contrast Enhanced MRI with MVD and Expression of VEGF in Nasopharyngeal Carcinoma
M.D. 2016 - Center for Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China Advisor: Li Li M.D
1. Liu LZ, Zhang GY, Xie CM, Liu XW, Cui CY, Li L. MR imaging of retropharyngeal lymphadenopathy in nasopharyngeal carcinoma: Patterns of spread. Int J Radiat Oncol Bio Phys, 66(3):721-730(2006).
2. Ma J, Liu LZ(Co-first author), Tang LL, Zong J, Lin AH, Lu TX, Cui NJ, Cui CY, Li L. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res, 13(5):1445-1452(2007).
3. Liu LZ, Liang SB, Li L, Mao YP, Tang LL, Tian L, Liao XB, Cui CY, Lin AH, Ma J. Prognostic impact of magnetic resonance imaging-detected cranial nerve involvment in nasopharyngeal carcinoma. Cancer , Cancer, 115(9):1995-2003(2009).
4. Cui CY, Liu LZ (Co-first author), Ma J, Liang SB, Tian L, Tang LL, Li L*. Trigeminal nerve palsy in nasopharyngeal carcinoma: Correlation between clinical findings and magnetic resonance imaging. Head Neck, 31(6):822-828 (2009).
5. Shao YZ, Liu LZ (Co-first author), Song SQ, Cao RH, Liu H, Cui CY, Li X, Bie MJ, Li L. A novel one-step synthesis of Gd(3+)-incorporated mesoporous SiO(2) nanoparticles for use as an efficient MRI contrast agent. Contrast Media Mol Imaging, 6(2):110-118(2011).
6. Chen L, Liu LZ (Co-first author), Mao YP, Tang LL, Sun Y, Chen Y, Lin AH, Li L, Ma J. Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma and its prognostic value. Head Neck, 33(9):1309-1314(2011).
7. Chen L, Liu LZ (Co-first author), Chen M, Li WF, Yin WJ, Lin AH, Sun Y, Li L, Ma J. Prognostic Value of Subclassification Using MRI in the T4 Classification Nasopharyngeal Carcinoma Intensity-Modulated Radiotherapy Treatment.Int J Radiat Oncol Biol Phys, 84(1):196-202(2012).
8. Tian Li, Liu LZ (Corresponding author), Cui CY, Zhang WD, Kuang YL. CT findings of primary non-teratomatous germ cell tumors of the mediastinum—A report of 15 cases European Journal of Radiology, 81(5):1057-1061(2012).
9. Shao YZ, Liu LZ (Co-first author), Bie MJ, Li CC, Wu YP, Xie XM, Li L.Characterizing the Clustered Microcalcifications on Mammograms to Predict the Pathological Classification and Grading: A mathematical modeling approach. Journal of Digital Imaging, 24 (5):764-71(2011).
10. Mo-Fa Gu, Liu LZ (Co-first author), Long-Jun He,Wen-Xin Yuan,Rong Zhang,Guang-Yu Luo,Guo-Liang Xu,Hua-Man Zhang,Chao-Xian Yan and Jian-Jun Li:Sequential Chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma. International Journal of Cancer, 132(1):215-223(2013).
11. Cai H, Liu LZ (Co-first author), Peng Y, Wu Y, Li L. Diagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocols.BMC Cancer, 14(2):366(2014).
12. Chen XL, Qiu ZW, Gu MF, Su Y, Liu LZ*, Liu Y, Mo CW, Xu Q, Sun J, Li DH.Translation and validation of the Chinese version of the Quality OF Life Radiation Therapy Instrument and the Head & Neck Module (QOL-RTI/H&N).Health Qual Life Outcomes, 12:51(2014).
13. Liu X, Liu LZ (Co-first author), Mao YP, Chen L, Tang LL, Zhou GQ, Sun Y, Yue D, Lin AH, Li L, Ma J*. Prognostic value of magnetic resonance imaging-detected cranial nerve invasion innasopharyngeal carcinoma. Br J Cancer, 110(6):1465-71 (2014).
14. Cheng YK, Liu LZ (Co-first author), Jiang N, Yue D, Tang LL, Zhang F, Lin L, Liu X, Chen L, Ma J*. MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma.Strahlenther Onkol, 190(10):905-11(2014).
15. Zhang GY , Liu LZ, Wei WH, Deng WM , Li YZ, Liu XW. Radiologic Criteria of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Treated with Radiation Therapy. Radiology, 255(2):605-612(2010).
16. Tang LL, Mao YB, Liu LZ Liang SB, Chen Y, Sun Y, Liao X, Lin AH, Liu MZ, Li L, Ma J. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer, 115(3):680-688( 2009).
17. Mao YP, Xie FY, Liu LZ, Sun Y, Li L, Tang LL, Liao XB, Xu HY, Chen L, Lai SZ, Lin AH, Liu MZ, Ma J. Re-evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys, 73(5):1326-1334(2009).
18. Liang SB, Sun Y, Liu LZ, Chen Y, Chen L, Mao YP, Tang LL, Tian L, Lin AH, Liu MZ, Li L, Ma J.Extension of Local Disease in Nasopharyngeal Carcinoma Detected by Magnetic Resonance Imaging: Improvement of Clinical Target Volume Delineation. Int J Radiat Oncol Biol Phys, 75(3):742-750(2009).
19. Chen L, Mao YP, Xie FY, Liu LZ, Sun Y, Tian L, Tang LL, Lin AH, Li L, Ma J. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol, 104(3):331-7(2012).
20. Tang LL, Li WF, Chen L, Sun Y, Chen Y, Liu LZ, Mao YP, Lin AH, Li L, Ma J. Prognostic value and staging categories of anatomic masticator space involvement in nasopharyngeal carcinoma: a study of 924 cases with MR imaging. Radiology, 257(1):151-157(2010).
21. Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J. How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients? Int J Radiat Oncol Biol Phys, 80(3):661-668(2011).
22. Li JJ, Gu MF, Luo GY, Liu LZ, Zhang R, Xu GL.Complications of high intensity focused ultrasound for patients with hepatocellular carcinoma. Technol Cancer Res Treat, 8(3):217-24(2009).
23. Li JJ, Gu MF, Pan K, Liu LZ Zhang H, Shen WX, Xia JC.Autologous Cytokine-induced Killer Cell Transfusion in Combination With Gemcitabine Plus Cisplatin Regimen Chemotherapy for Metastatic Nasopharyngeal Carcinoma. J Immunother, 35(2):189-95(2012).
Last Updated on: September 2018
Associate Professor, Department of Radiology, Cancer Center, Sun Yat-sen University, Guangzhou, P.R.China(2009~)
Attending Radiologist, Department of Radiology, Cancer Center, Sun Yat-sen University, Guangzhou, P.R.China (1991~2009)
Resident, Department of Radiology, Cancer Center, Sun Yat-sen University, Guangzhou, P.R.China (1984~1991)
Bachelor of Medical Sciences from Sun Yat-sen University of Medical Sciences in 1984Master of Medical Sciences from Sun Yat-sen University of Medical Sciences in 2001
Fourth type of time-signal curve in 3D dynamic MR breast lesions (Journal of the Fourth Molitary Medical University Vol.29 No.24 Dec.31 2008)
Diagnostic Values of CT Perfusion Imaging in Pulmonary Masses(Chinese Journal of Cancer,2007,Vol.26 No.1)
Last Updated on: July 2015
Dr. Fei Gao is associate professor of Medical Imaging and Interventional Radiology. He obtained his Ph.D. at Sun Yat-sen University Cancer Center, P. R. China in 2012. His postdoctoral training at University of Rochester University Medical Center provided him with great opportunities to explore the fields of Y90 treatment for HCC, TIPS and solid tumor ablations guided by TPS. Dr. Gao has published more than 10 research papers.
1.Microwave ablation for solid tumors.
2.Study on the advantage of treatment for hepatic carcinoma with hypersplenism by TACE combined with splenic microwave ablation.
3.Biliary stents placement
6/20/2003 Bachelor of Medical ImagingSun Yat-sen UniversityGuangzhou, China
6/22/2009 Master of Medical ImagingSun Yat-sen University Guangzhou, China
6/26/2012 M.D. of Oncology,Sun Yat-sen University Guangzhou, China
1. Gao F, Gu YK, Huang JH, Zhao M, Wu PH. Radiofrequency Ablation of Retroperitoneal Metastatic Lymph Nodes from Hepatocellular Carcinoma Acad Radiol 2012;19:1035-1040.
2. Gao F, Li CX, Gu YK, Huang JH, Zhang FJ, Wu PH. CT-guided 125I brachytherapy for Mediastinal Metastatic Lymph Nodes Recurrence from Esophageal Carcinoma: Effectiveness and Safety in 16 Patients. Eur J Radiol 2013;82:e70-e75.
3. Gao F, Gu YK, Fan WJ, Zhang L, Huang JH. Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma.World J Gastroenterol 2011; 26:3145-3150.
4. Gao F, Gu YK, Shen JX, Li CL, Jiang XY, Huang JH. Experimental study of destruction to porcine spleen in vivo by microwave ablation.World J Gastroenterol. 2011;45:5014-5020.
5. Gao F, Zhong R, Li GH, Zhang WD. Computed tomography and magnetic resonance imaging findings of inflammatory myofibroblastic tumors of the head and neck. Acta Radiol. 2013 Aug 21. [Epub ahead of print]
6. Jingxian Shen, Fei Gao*, Jing Zhao, Yunxian Mo, Peihong Wu. Small hepatocellular carcinoma keeping hypodense during dual phase helical CT scan and correlative pathology. J Biomed Graph Comput 2013;3:1-7. （* Corresponding author）
7. Yongxin Chen, Fei Gao*, Lin Chen, Sheng Peng, Yingjie Huang, Yao Wang. Effectiveness and Safety of CT-Guided 125I Brachytherapy for Lung Metastasis from Hepatocellular Carcinoma. Open Journal of Radiology 2013;3:159-164. （* Corresponding author）
8. Luo RG, Gao F, Gu YK, Huang JH, Li CL. Radioablation settings affecting the size of lesions created ex vivo in porcine livers with monopolar perfusion electrodes.Acad Radiol 2010;8:980-984.
9. Luo RG, Gao F, Huang JH, Jiang XY, Huang YJ. Experimental study on diluted hydrochloric acid enlarging radiofrequency ablation lesions in excised porcine livers. Diagnostic and Interventional Radiology 2012. doi:10.4261 /1305-3825. DIR. 6093-12.1.
10. Huang JH, Gao F, Gu YK, Li WQ, Lu LW. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterology 2007; 48:6593-6597.
M.D. 1999 Sun Yat-sen University
M.S. 2004 State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
Ph.D. 2013 State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
1. Wu YP, Zhang WZ, Li L, Guo RP, Xie CM, Cai PQ. Comparison of therapeutic effects between transcatheter arterial chemoembolization and transcatheter arterial-portal venous double chemoembolization in treatment of moderate and advanced stages of primary liver carcinoma. Ai Zheng. 2003 Aug;22(8):880-3. Chinese. PMID: 12917041 [PubMed - indexed for MEDLINE]
2. Wu YP, Cai PQ, Zhang WZ, Tang J, Gu YK, Li L, Ouyang Y, He JH, Lin HG. Clinical evaluation of three methods of fine-needle aspiration, large-core needle biopsy and frozen section biopsy with focus staining for non-palpable breast disease. Ai Zheng. 2004 Mar; 23(3):346-9. Chinese. PMID: 15025973 [PubMed - indexed for MEDLINE]
3. Cai PQ, Xie CM, Wu YP, Zhang WZ. CT Imaging of Gastric Stromal Tumor. Guangzhou Medical Journal. 2004 Nov 20; 35 (6):32-34. Chinese.
4. Zhang WD, Zhao LL, Huang XB, Cai PQ, Xu GX. Computed tomography imaging of anterior and middle mediastinal Ewing sarcoma/primitive neuroectodermal tumors. J Thorac Imaging. 2010 May; 25(2):168-72.
5. Li YZ, Wu PH, Huang ZL, Xie CM, Zhang GY, Lu CY, Li L, Cai PQ, Liu XW. Distributions of primary nasopharyngeal carcinoma tumor and patterns of skull base erosion detected by magnetic resonance imaging. Zhonghua Yi Xue Za Zhi. 2010 Dec 21; 90(47):3347-50. Chinese. PMID: 21223751 [PubMed - indexed for MEDLINE]
6. Zeng R, Dai Q, Peng Z, Cai P, Hu W. Prediction of occult cervical lymph node metastasis in clinically negative supraglottic squamous cell carcinoma. Head Neck Oncol. 2012 Oct 27; 4 (3):69.
7. Li YZ, Cai PQ, Xie CM, Huang ZL, Zhang GY, Wu YP, Liu LZ, Lu CY, Zhong R, Wu PH. Nasopharyngeal cancer: impact of skull base invasion on patients prognosis and its potential implications on TNM staging. Eur J Radiol. 2013 Mar; 82(3):e107-11.
8. Luo GY, Cai PQ, He JH, Li JJ, Li Y, Shan HB, Zhang R, Gao XY, Lao XM, Xu GL. Application of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Management of Mediastinal and Hilar Lymphadenopathy Without Intrapulmonary Mass: Experience from the Largest Cancer Center of Southern China. Cell Biochem Biophys. 2013 Dec. 31;67(3):1533-8
9. An X, Lin X, Wang FH, Goodman K, Cai PQ, Kong LH, Fang YJ, Gao YH, Lin JZ, Wan DS, Pan ZZ, Ding PR. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis. Eur J Cancer. 2013 Mar; 49(4):843-51.
10. Kuang BH, Wen XZ, Ding Y, Peng RQ, Cai PQ, Zhang MQ, Jiang F, Zhang XS, Zhang X. The prognostic value of platelet endothelial cell adhesion molecule-1 in non-small-cell lung cancer patients. Med Oncol. 2013 Jun; 30(2):536.
11. Lv XF, Ye M, Han LJ, Zhang XL, Cai PQ, Jiang GH, Qiu YW, Qiu SJ, Wu YP, Liu K, Liu ZY, Wu PH, Xie CM. Abnormal baseline brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI. Metab Brain Dis. 2013 Sep; 28(3):485-92.
12. Cai PQ, Wu YP, Xie CM, et al. Hepatic angiomyolipoma: CT and MR imaging findings with clinical-pathologic comparison. Abdom Imaging. 2013 Jun; 38(3):482-9.
13. Cai PQ, Wu YP, Li L, Zhang R, Xie CM, Wu PH, Xu JH. CT and MRI of radiation-induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. Clin Radiol. 2013 Jul; 68(7):683-9.
14. Cai PQ, Li YZ, Zeng RF, Xu JH, Xie CM, Wu YP, Wu PH. Nasopharyngeal tuberculosis: CT and MRI findings in thirty-six patients. Eur J Radiol. 2013 Sep; 82(9):e448-54.
15. Luo RZ, Cai PQ, Li M, Fu J, Zhang ZY, Chen JW, Cao Y, Yun JP, Xie D, Cai MY. Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma. PLoS One. 2014 Jan 24;9(1):e85592.
16. Cai PQ, Wu YP, An X, Qiu X, Kong LH, Liu GC, Xie CM, Pan ZZ, Wu PH, Ding PR. Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2014 Jul 20. [Epub ahead of print]
17. Tian L, Cai PQ, Cui CY, Mo YX, Gong X, Fan W. Reactive thymic hyperplasia following chemotherapy for children with lymphoma: computed tomography may be able to provide valuable information to avoid over-treatment. Eur J Cardiothorac Surg. 2014 Jul 30. pii: ezu303.
18. Yao-Pan Wu, Cai PQ, Li Tian, Jie-Hua Xu, Richard Alan Mitteer Jr, Yi Fan, Zhenfeng Zhang. Hypertrophic adenoids in patients with nasopharyngeal carcinoma: appearance at magnetic resonance imaging before and after treatment. Chinese Journal of Cancer (2015) 34:4
19. Cai PQ, Xiao-Fei Lv, Li Tian, Zhuo-Peng Luo, R. Alan Mitteer Jr., Yi Fan, Yao-Pan Wu. CT Characterization of Duodenal Gastrointestinal Stromal Tumors. AJR 2015; 204:988–993